-
1
-
-
0025079988
-
Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure
-
ABASSI, Z., HARAMATI, A., HOFFMAN, A., BURNETT, J. C. AND WINAVER, J.: Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am. J. Physiol. 259: R84-R89, 1990.
-
(1990)
Am. J. Physiol.
, vol.259
-
-
Abassi, Z.1
Haramati, A.2
Hoffman, A.3
Burnett, J.C.4
Winaver, J.5
-
2
-
-
0027302223
-
Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently
-
ARNAL, J. F., EL AMRANI, K. AND MICHEL, J. B.: Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently. Eur. J. Pharmacol. 237: 265-273, 1993.
-
(1993)
Eur. J. Pharmacol.
, vol.237
, pp. 265-273
-
-
Arnal, J.F.1
El Amrani, K.2
Michel, J.B.3
-
3
-
-
0024439344
-
Effects of propranolol and pindolol on plasma levels in humans at rest and during exercise
-
BOUISSOU, P., GALEN, F. X., RICHALET, J. P., LARTIGUE, M., DEVAUX, F., DUBRAY, C. AND ATLAN, G.: Effects of propranolol and pindolol on plasma levels in humans at rest and during exercise. Am. J. Physiol. 257: R259-R264, 1989.
-
(1989)
Am. J. Physiol.
, vol.257
-
-
Bouissou, P.1
Galen, F.X.2
Richalet, J.P.3
Lartigue, M.4
Devaux, F.5
Dubray, C.6
Atlan, G.7
-
4
-
-
0028243301
-
Effects of alatnopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction: Comparison with captopril
-
BRALET, J., MARIE, C., MOSSIAT, C., LECOMTE, J. M., GROS, C. AND SCHARTZ, J. C.: Effects of alatnopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction: Comparison with captopril. J. Pharmacol. Exp. Ther. 270: 8-14, 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.270
, pp. 8-14
-
-
Bralet, J.1
Marie, C.2
Mossiat, C.3
Lecomte, J.M.4
Gros, C.5
Schartz, J.C.6
-
5
-
-
0025993803
-
Thiorphan-induced natriuresis in volume-expanded rats: Roles of endogenous atrial natriuretic factor and kinins
-
BRALET, J., MOSSIAT, C., GROS, C. AND SCHWARTZ, J. C.: Thiorphan-induced natriuresis in volume-expanded rats: Roles of endogenous atrial natriuretic factor and kinins. J. Pharmacol. Exp. Ther. 258: 807-811, 1991.
-
(1991)
J. Pharmacol. Exp. Ther.
, vol.258
, pp. 807-811
-
-
Bralet, J.1
Mossiat, C.2
Gros, C.3
Schwartz, J.C.4
-
6
-
-
0025361954
-
Diverse biological actions of atrial natriuretic peptide
-
BRENNER, B. M., BALLERMANN, B. J., GUNNING, M. E. AND ZEIDEL, M. L.: Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70: 665-690, 1990.
-
(1990)
Physiol. Rev.
, vol.70
, pp. 665-690
-
-
Brenner, B.M.1
Ballermann, B.J.2
Gunning, M.E.3
Zeidel, M.L.4
-
7
-
-
0022471069
-
Atrial natriuretic peptide elevation in congestive heart failure in the human
-
Wash. DC
-
BURNETT, J., KAO, P., HU, D. C., HESER, W., HEUBLEIN, D., GRANGER, J. P., OPGENORTH, T. AND REEDER, G.: Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Wash. DC) 231: 1145-1147, 1986.
-
(1986)
Science
, vol.231
, pp. 1145-1147
-
-
Burnett, J.1
Kao, P.2
Hu, D.C.3
Heser, W.4
Heublein, D.5
Granger, J.P.6
Opgenorth, T.7
Reeder, G.8
-
8
-
-
0023922293
-
Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension
-
CARBONELL, L. F., CARRETERO, O. A., STEWART, J. M. AND SCICLI, A. G.: Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension 11: 239-243, 1988.
-
(1988)
Hypertension
, vol.11
, pp. 239-243
-
-
Carbonell, L.F.1
Carretero, O.A.2
Stewart, J.M.3
Scicli, A.G.4
-
9
-
-
0019382052
-
Role of kinins in acute antihypertensive effect of the converting enzyme inhibitor, captopril
-
CARRETERO, O., MIYAZAKI, S. AND SCICLI, A.: Role of kinins in acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension 3: 18-22, 1981.
-
(1981)
Hypertension
, vol.3
, pp. 18-22
-
-
Carretero, O.1
Miyazaki, S.2
Scicli, A.3
-
10
-
-
0025324969
-
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
-
CAVERO, P., MARGULIES, K., WINAVER, J., SEYMOUR, A., DELANEY, N. AND BURNETT, J.: Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation 82: 196-201, 1990.
-
(1990)
Circulation
, vol.82
, pp. 196-201
-
-
Cavero, P.1
Margulies, K.2
Winaver, J.3
Seymour, A.4
Delaney, N.5
Burnett, J.6
-
11
-
-
0023839979
-
Increased ANF secretion after volume expansion is preserved in rats with heart failure
-
CHIEN, Y., BARBEE, W., MACPHEE, A., FROHLICH, E. AND TRIPPODO, N.: Increased ANF secretion after volume expansion is preserved in rats with heart failure. Am. J. Physiol. 254: R185-R191, 1988.
-
(1988)
Am. J. Physiol.
, vol.254
-
-
Chien, Y.1
Barbee, W.2
Macphee, A.3
Frohlich, E.4
Trippodo, N.5
-
12
-
-
0023023302
-
Atrial natriuretic factor in normal subjects and heart failure
-
CODY, R., LARAGH, J., KUBO, S., COVIT, B., RYMAN, S. AND SHAKNOVICH, A.: Atrial natriuretic factor in normal subjects and heart failure. J. Clin. Invest. 78: 1362-1374, 1986.
-
(1986)
J. Clin. Invest.
, vol.78
, pp. 1362-1374
-
-
Cody, R.1
Laragh, J.2
Kubo, S.3
Covit, B.4
Ryman, S.5
Shaknovich, A.6
-
13
-
-
0023195322
-
Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure
-
DING, J., THIBAULT, G., GUTKOWSKA, J., GARCIA, R., KARABATSOS, T., JASMIN, G., GENEST, J. AND CANTIN, M.: Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology 121: 248-257, 1987.
-
(1987)
Endocrinology
, vol.121
, pp. 248-257
-
-
Ding, J.1
Thibault, G.2
Gutkowska, J.3
Garcia, R.4
Karabatsos, T.5
Jasmin, G.6
Genest, J.7
Cantin, M.8
-
14
-
-
0027180453
-
Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combinated inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11
-
FLYNN, G. A., BEIGHT, D. W., MEHDI, S., KOEHL, J. R., GIROUX, E. L., FRENCH, J. F., HAKE, P. W. AND DAGE, R. C.: Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combinated inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11. J. Med. Chem. 36: 2420-2423, 1993.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2420-2423
-
-
Flynn, G.A.1
Beight, D.W.2
Mehdi, S.3
Koehl, J.R.4
Giroux, E.L.5
French, J.F.6
Hake, P.W.7
Dage, R.C.8
-
15
-
-
0028299371
-
New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: Rational design, bioavailability, and pharmacological responses in experimental hypertension
-
FOURNIÉ-ZALUSKI, M. C., CORIC, P., TURCAUD, S., ROUSSELET, N., GONZALEZ, W., BARBE, B., PHAM, I., JULLIAN, N., MICHEL, J. B. AND ROQUES, B. P.: New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: Rational design, bioavailability, and pharmacological responses in experimental hypertension. J. Med. Chem. 37: 1070-1083, 1994a.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 1070-1083
-
-
Fournié-Zaluski, M.C.1
Coric, P.2
Turcaud, S.3
Rousselet, N.4
Gonzalez, W.5
Barbe, B.6
Pham, I.7
Jullian, N.8
Michel, J.B.9
Roques, B.P.10
-
16
-
-
0028298070
-
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: A potential therapeutic approach in hypertension
-
FOURNIÉ-ZALUSKI, M. C., GONZALEZ, W., TURCAUD, S., PHAM, I., ROQUES, B. P. AND MICHEL, J. B.: Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: A potential therapeutic approach in hypertension. Proc. Natl. Acad. Sci. U.S.A. 91: 4072-4076, 1994b.
-
(1994)
Proc. Natl. Acad. Sci. U.S.A.
, vol.91
, pp. 4072-4076
-
-
Fournié-Zaluski, M.C.1
Gonzalez, W.2
Turcaud, S.3
Pham, I.4
Roques, B.P.5
Michel, J.B.6
-
17
-
-
0021211669
-
The neurohumoral axis in congestive heart failure
-
FRANCIS, G. S., GOLDSMITH, T. B., LEVINE, T., OLIVARI, M. AND COHN, J. N.: The neurohumoral axis in congestive heart failure. Ann. Intern. Med. 101: 370-377, 1984.
-
(1984)
Ann. Intern. Med.
, vol.101
, pp. 370-377
-
-
Francis, G.S.1
Goldsmith, T.B.2
Levine, T.3
Olivari, M.4
Cohn, J.N.5
-
18
-
-
0028962349
-
ANF and angiotensin II interact via kinases in the proximal straight tubule
-
GARCIA, N. AND GARVIN, J. L.: ANF and angiotensin II interact via kinases in the proximal straight tubule. Am. J. Physiol. 268: F730-F735, 1995.
-
(1995)
Am. J. Physiol.
, vol.268
-
-
Garcia, N.1
Garvin, J.L.2
-
19
-
-
0024448212
-
Mechanism mediating hypertensive effect of ANF in sodium-depleted dogs
-
GRANGER, J. P., MEADOWS, E., SOOUDI, S. AND STACY, L.: Mechanism mediating hypertensive effect of ANF in sodium-depleted dogs. Am. J. Physiol. 257: H502-H505, 1989.
-
(1989)
Am. J. Physiol.
, vol.257
-
-
Granger, J.P.1
Meadows, E.2
Sooudi, S.3
Stacy, L.4
-
20
-
-
0027435581
-
Glomerular atrial natriuretic factor receptors in experimental congestive heart failure
-
ISNARD, R., CARAYON, A., EURIN, J., MAISTRE, G., BOUANANI, N., BARTHELEMY, C., CROZATIER, B., KOMAJDA, M. AND LEGRAND, J.-C.: Glomerular atrial natriuretic factor receptors in experimental congestive heart failure. Am. J. Physiol. 265: H923-H928, 1993.
-
(1993)
Am. J. Physiol.
, vol.265
-
-
Isnard, R.1
Carayon, A.2
Eurin, J.3
Maistre, G.4
Bouanani, N.5
Barthelemy, C.6
Crozatier, B.7
Komajda, M.8
Legrand, J.-C.9
-
21
-
-
0024282457
-
Role of endopeptidase 24.11 in inactivation of atrial natriuretic peptide
-
KENNY, A. J. AND STEPHENSON, S. L.: Role of endopeptidase 24.11 in inactivation of atrial natriuretic peptide. FEBS Lett. 232: 507-513, 1988.
-
(1988)
FEBS Lett.
, vol.232
, pp. 507-513
-
-
Kenny, A.J.1
Stephenson, S.L.2
-
22
-
-
0024212111
-
Angiotensin converting enzyme inhibitors: Clinical use
-
KOSTIS, J. B.: Angiotensin converting enzyme inhibitors: Clinical use. Am. Heart J. 116: 1591-1605, 1988.
-
(1988)
Am. Heart J.
, vol.116
, pp. 1591-1605
-
-
Kostis, J.B.1
-
23
-
-
0022468421
-
Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process
-
KUHTZ, A., DELLABRUMA, R., PFEILSCHIFTER, J., TAUGNER, R. AND BAUER, C.: Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc. Natl. Acad. Sci. U.S.A. 83: 4769-4773, 1986.
-
(1986)
Proc. Natl. Acad. Sci. U.S.A.
, vol.83
, pp. 4769-4773
-
-
Kuhtz, A.1
Dellabruma, R.2
Pfeilschifter, J.3
Taugner, R.4
Bauer, C.5
-
24
-
-
0023197682
-
Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats
-
LAPPE, R. W., TODT, J. A. AND WENDT, R. L.: Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats. Circ. Res. 61: 134-140, 1987.
-
(1987)
Circ. Res.
, vol.61
, pp. 134-140
-
-
Lappe, R.W.1
Todt, J.A.2
Wendt, R.L.3
-
25
-
-
0025719871
-
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure
-
MARGULIES, K. B., PERELLA, M. A., MCKINLEY, J. AND BURNETT, J. C.: Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. J. Clin. Invest. 88: 1636-1642, 1991.
-
(1991)
J. Clin. Invest.
, vol.88
, pp. 1636-1642
-
-
Margulies, K.B.1
Perella, M.A.2
Mckinley, J.3
Burnett, J.C.4
-
26
-
-
0015295291
-
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I
-
MENARD, J. AND CATT, K. J.: Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90: 422-430, 1972.
-
(1972)
Endocrinology
, vol.90
, pp. 422-430
-
-
Menard, J.1
Catt, K.J.2
-
27
-
-
0004439571
-
Plasma atrial natriuretic peptide is elevated in rats with myocardial infarction and failure independent of sodium intake
-
MENDEZ, R., PFEFFER, J., ORTOLA, V., ANDERSON, S. AND BRENNER, B.: Plasma atrial natriuretic peptide is elevated in rats with myocardial infarction and failure independent of sodium intake. Kidney Int. 31: 279-281, 1987.
-
(1987)
Kidney Int.
, vol.31
, pp. 279-281
-
-
Mendez, R.1
Pfeffer, J.2
Ortola, V.3
Anderson, S.4
Brenner, B.5
-
28
-
-
0023818833
-
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction
-
MICHEL, J. B., LATTION, A. L., SALZMAN, J. L., CEROL, M. L., PHILIPPE, M., CAMILLERI, J. P. AND CORVOL, P.: Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ. Res. 62:641-650, 1988.
-
(1988)
Circ. Res.
, vol.62
, pp. 641-650
-
-
Michel, J.B.1
Lattion, A.L.2
Salzman, J.L.3
Cerol, M.L.4
Philippe, M.5
Camilleri, J.P.6
Corvol, P.7
-
29
-
-
0025109591
-
Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats
-
MICHEL, J. B., MERCADIER, J. J., GALEN, F. X., URBAIN, R., DUSSAULE, J. C., PHILIPPE, M. AND CORVOL, P.: Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc. Res. 25: 946-952, 1990.
-
(1990)
Cardiovasc. Res.
, vol.25
, pp. 946-952
-
-
Michel, J.B.1
Mercadier, J.J.2
Galen, F.X.3
Urbain, R.4
Dussaule, J.C.5
Philippe, M.6
Corvol, P.7
-
30
-
-
0024351109
-
Atrial natriuretic peptide and pressure natriuresis: Interactions with the renin-angiotensin system
-
MIZELLE, H. L., HALL, J. E. AND HILDBRANDT, D. A.: Atrial natriuretic peptide and pressure natriuresis: Interactions with the renin-angiotensin system. Am. J. Physiol. 257: R1169-R1174, 1989.
-
(1989)
Am. J. Physiol.
, vol.257
-
-
Mizelle, H.L.1
Hall, J.E.2
Hildbrandt, D.A.3
-
31
-
-
0026560584
-
Pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure
-
MOE, G. W., CANEPA-ANSON, R. AND ARMSTRONG, P. W.: Pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. J. Cardiovasc. Pharmacol. 19: 691-700, 1992.
-
(1992)
J. Cardiovasc. Pharmacol.
, vol.19
, pp. 691-700
-
-
Moe, G.W.1
Canepa-Anson, R.2
Armstrong, P.W.3
-
32
-
-
0026656292
-
Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure
-
MUNZEL, T., KURZ, S., HOLTZ, J., BUSSE, R., STEINHAUER, H., JUST, H. AND DREXLER, H.: Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation 86: 1089-1098, 1992.
-
(1992)
Circulation
, vol.86
, pp. 1089-1098
-
-
Munzel, T.1
Kurz, S.2
Holtz, J.3
Busse, R.4
Steinhauer, H.5
Just, H.6
Drexler, H.7
-
33
-
-
0018405511
-
Myocardial infarct size and ventricular function in rats
-
PFEFFER, M., PFEFFER, J., FISHBEIN, M., FLETCHER, J., SPARADO, J., KLONER, R. AND BRAUNWALD, E.: Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
-
(1979)
Circ. Res.
, vol.44
, pp. 503-512
-
-
Pfeffer, M.1
Pfeffer, J.2
Fishbein, M.3
Fletcher, J.4
Sparado, J.5
Kloner, R.6
Braunwald, E.7
-
34
-
-
0026676636
-
Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats
-
PHAM, I., EL AMRANI, A.-I., FOURNIÉ-ZALUSKI, M. C., CORVOL, P., ROQUES, B. P. AND MICHEL, J. B.: Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats. J. Cardiovasc. Pharmacol. 20: 847-857, 1992.
-
(1992)
J. Cardiovasc. Pharmacol.
, vol.20
, pp. 847-857
-
-
Pham, I.1
El Amrani, A.-I.2
Fournié-Zaluski, M.C.3
Corvol, P.4
Roques, B.P.5
Michel, J.B.6
-
35
-
-
0030026249
-
Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: Influence of bradykinin
-
PHAM, I., GONZALEZ, W., DOUCET, J., FOURNIÉ-ZALUSKI, M. C., ROQUES, B. P. AND MICHEL, J. B.: Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: Influence of bradykinin. Eur. J. Pharmacol. 296: 267-276, 1995.
-
(1995)
Eur. J. Pharmacol.
, vol.296
, pp. 267-276
-
-
Pham, I.1
Gonzalez, W.2
Doucet, J.3
Fournié-Zaluski, M.C.4
Roques, B.P.5
Michel, J.B.6
-
36
-
-
0027440877
-
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension
-
PHAM, I., GONZALEZ, W., EL AMRANI, A.-K., FOURNIÉ-ZALUSKI, M. C., PHILIPPI, M., LABOULANDINE, I., ROQUES, B. P. AND MICHEL, J. B.: Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J. Pharmacol. Exp. Ther. 265: 1339-1347, 1993.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.265
, pp. 1339-1347
-
-
Pham, I.1
Gonzalez, W.2
El Amrani, A.-K.3
Fournié-Zaluski, M.C.4
Philippi, M.5
Laboulandine, I.6
Roques, B.P.7
Michel, J.B.8
-
37
-
-
0022509596
-
Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
-
RAINE, A. E., ERNE, P., BURGISSER, E., MULLER, F. B., BOLLI, P., BURKART, F. AND BUHLER, F. R.: Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N. Engl. J. Med. 315: 533-537, 1986.
-
(1986)
N. Engl. J. Med.
, vol.315
, pp. 533-537
-
-
Raine, A.E.1
Erne, P.2
Burgisser, E.3
Muller, F.B.4
Bolli, P.5
Burkart, F.6
Buhler, F.R.7
-
38
-
-
0025374430
-
Neutral endopeptidase-24.11 inhibitors: From analgesics to antihypertensives?
-
ROQUES, B. P. AND BEAUMONT, A.: Neutral endopeptidase-24.11 inhibitors: From analgesics to antihypertensives? Trends Pharmacol. Sci. 11: 245-249, 1990.
-
(1990)
Trends Pharmacol. Sci.
, vol.11
, pp. 245-249
-
-
Roques, B.P.1
Beaumont, A.2
-
39
-
-
0027475050
-
Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology
-
ROQUES, B. P., NOBLE, F., DAUGÉ, V., FOURNIÉ-ZALUSKI, M. C. AND BEAUMONT, A.: Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45: 87-146, 1993.
-
(1993)
Pharmacol. Rev.
, vol.45
, pp. 87-146
-
-
Roques, B.P.1
Noble, F.2
Daugé, V.3
Fournié-Zaluski, M.C.4
Beaumont, A.5
-
40
-
-
0025881568
-
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors
-
SEYMOUR, A., NORMAN, J., ASAAD, M., FENELL, S., ABBOA-OFFEI, B., LITTLE, D., KRATUNIS, V., DELANEY, N., HUNT, J. AND DI DONATO, G.: Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. J. Pharmacol. Exp. Ther. 256: 1002-1009, 1990.
-
(1990)
J. Pharmacol. Exp. Ther.
, vol.256
, pp. 1002-1009
-
-
Seymour, A.1
Norman, J.2
Asaad, M.3
Fenell, S.4
Abboa-Offei, B.5
Little, D.6
Kratunis, V.7
Delaney, N.8
And, H.J.9
Di Donato, G.10
-
41
-
-
0027519535
-
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure
-
SEYMOUR, A. A., ASAAD, M. M., LANOCE, V. M., LANGENBACHER, K. M., FENNELL, S. A. AND ROGERS, W. L.: Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. J. Pharmacol. Exp. Ther. 266: 872-883, 1993.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.266
, pp. 872-883
-
-
Seymour, A.A.1
Asaad, M.M.2
Lanoce, V.M.3
Langenbacher, K.M.4
Fennell, S.A.5
Rogers, W.L.6
-
42
-
-
0028293527
-
Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs
-
SEYMOUR, A. A., SHELDON, J. H., SMITH, P. L., ASAAD, M. AND ROGERS, W. L.: Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs. J. Pharmacol. Exp. Ther. 269: 263-270, 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.269
, pp. 263-270
-
-
Seymour, A.A.1
Sheldon, J.H.2
Smith, P.L.3
Asaad, M.4
Rogers, W.L.5
-
43
-
-
0023951876
-
Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II
-
SHOWALTER, C. J., ZIMMERMAN, R. S., SCHWAB, T. R., EDWARDS, B. S., OPGENORTH, T. J. AND BURNETT, J. J.: Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am. J. Physiol. 254: R453-R456, 1988.
-
(1988)
Am. J. Physiol.
, vol.254
-
-
Showalter, C.J.1
Zimmerman, R.S.2
Schwab, T.R.3
Edwards, B.S.4
Opgenorth, T.J.5
Burnett, J.J.6
-
44
-
-
0023278590
-
Human renal angiotensin I converting enzyme and neutral endopeptidase
-
SKIDGEL, R. A., SCHULTZ, W. W., TAM, L. T. AND ERDOS, E. G.: Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int. 31: 45-48, 1987.
-
(1987)
Kidney Int.
, vol.31
, pp. 45-48
-
-
Skidgel, R.A.1
Schultz, W.W.2
Tam, L.T.3
Erdos, E.G.4
-
45
-
-
0025312661
-
Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: Renal effects
-
SMITS, G. J., MCGRAW, D. E. AND THAPANI, A. J.: Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: Renal effects. Am. J. Physiol. 268: F1417-F1424, 1990.
-
(1990)
Am. J. Physiol.
, vol.268
-
-
Smits, G.J.1
Mcgraw, D.E.2
Thapani, A.J.3
-
46
-
-
0027143192
-
Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors
-
STANTON, J. L., SPERBECK, D. M., TRAPANI, A. J., COTE, D., SAKANE, Y., BERRY, C. J. AND GHAI, R. D.: Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors. J. Med. Chem. 36: 3829-3833, 1993.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 3829-3833
-
-
Stanton, J.L.1
Sperbeck, D.M.2
Trapani, A.J.3
Cote, D.4
Sakane, Y.5
Berry, C.J.6
Ghai, R.D.7
-
47
-
-
0024435563
-
SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats
-
SYBERTZ, E., CHIU, P. J., VEMULAPALLI, S., PITTS, B., FOSTER, C., WATKINS, R., BARNETT, A. AND HASLANGER, M.: SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats. J. Pharmacol. Exp. Ther. 250: 624-631, 1989.
-
(1989)
J. Pharmacol. Exp. Ther.
, vol.250
, pp. 624-631
-
-
Sybertz, E.1
Chiu, P.J.2
Vemulapalli, S.3
Pitts, B.4
Foster, C.5
Watkins, R.6
Barnett, A.7
Haslanger, M.8
-
48
-
-
0025787148
-
SCH 34826: An overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator
-
SYBERTZ, E. J.: SCH 34826: An overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator. Clin. Nephrol. 36:187-191, 1991.
-
(1991)
Clin. Nephrol.
, vol.36
, pp. 187-191
-
-
Sybertz, E.J.1
-
49
-
-
0027448911
-
Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure
-
TRIPPODO, N. C., FOX, M., NATARAJAN, V., PANCHAL, B. C., DORSO, C. R. AND ASAAD, M. M.: Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure. J. Pharmacol. Exp. Ther. 267: 108-116, 1993.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.267
, pp. 108-116
-
-
Trippodo, N.C.1
Fox, M.2
Natarajan, V.3
Panchal, B.C.4
Dorso, C.R.5
Asaad, M.M.6
-
50
-
-
0028819075
-
Repression of angiotensin II and potentiation of bradykinin contribute to the synergestic effects of dual metalloprotease inhibition in heart failure
-
TRIPPODO, N. C., PANCHAL, B. C. AND FOX, M.: Repression of angiotensin II and potentiation of bradykinin contribute to the synergestic effects of dual metalloprotease inhibition in heart failure. J. Pharmacol. Exp. Ther. 272: 619-627, 1995a.
-
(1995)
J. Pharmacol. Exp. Ther.
, vol.272
, pp. 619-627
-
-
Trippodo, N.C.1
Panchal, B.C.2
Fox, M.3
-
51
-
-
0029619616
-
Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase/angiotensin converting enzyme BMS-182657 in experimental hypertension and heart failure
-
TRIPPODO, N. C., ROBL, J., ASAAD, M. M., BIRD, J. E., PANCHAL, B. C., SCHAEFFER, T. R., FOX, M., GIANCARLI, M. R. AND CHEUNG, H. S.: Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase/angiotensin converting enzyme BMS-182657 in experimental hypertension and heart failure. J. Pharmacol. Exp. Ther. 275: 745-752, 1995b.
-
(1995)
J. Pharmacol. Exp. Ther.
, vol.275
, pp. 745-752
-
-
Trippodo, N.C.1
Robl, J.2
Asaad, M.M.3
Bird, J.E.4
Panchal, B.C.5
Schaeffer, T.R.6
Fox, M.7
Giancarli, M.R.8
Cheung, H.S.9
-
52
-
-
0023200788
-
Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo
-
URA, N., CARRETERO, O. A. AND ERDOS, E. G.: Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 32: 507-513, 1987.
-
(1987)
Kidney Int.
, vol.32
, pp. 507-513
-
-
Ura, N.1
Carretero, O.A.2
Erdos, E.G.3
-
53
-
-
0023942416
-
Hormonal determinations of sodium excretion in rats with experimental high-output heart failure
-
WINAVER, J., HOFFMAN, A., BURNETT, J. C. AND HARAMATI, A.: Hormonal determinations of sodium excretion in rats with experimental high-output heart failure. Am. J. Physiol. 254: R776-R784, 1988.
-
(1988)
Am. J. Physiol.
, vol.254
-
-
Winaver, J.1
Hoffman, A.2
Burnett, J.C.3
Haramati, A.4
-
54
-
-
0024203272
-
Urinary cGMP as a biological marker of the renal activity of atrial natriuretic factor
-
WONG, K. R., XIE, M. H., SHI, L. B., LIU, F. Y., HUANG, C. L., GARDNER, D. G. AND COGAN, M. G.: Urinary cGMP as a biological marker of the renal activity of atrial natriuretic factor. Am. J. Physiol. 255: F1220-F1224, 1988.
-
(1988)
Am. J. Physiol.
, vol.255
-
-
Wong, K.R.1
Xie, M.H.2
Shi, L.B.3
Liu, F.Y.4
Huang, C.L.5
Gardner, D.G.6
Cogan, M.G.7
-
55
-
-
0028856298
-
Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure
-
ZHANG, P. L., MACKENZIE, H. S., TOTSUME, K., TROY, J. L. AND BRENNER, B. M.: Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure. Circ. Res. 77: 1240-1245, 1995.
-
(1995)
Circ. Res.
, vol.77
, pp. 1240-1245
-
-
Zhang, P.L.1
Mackenzie, H.S.2
Totsume, K.3
Troy, J.L.4
Brenner, B.M.5
|